References
- BENSOUSSAN, C., DELAFORGE, M. and MANSUY, D., 1995, Particular ability of cytochromes P450 3A to form inhibitory P450—iron-metabolite complexes upon metabolic oxidation of amino drugs. Biochemical Pharmacology, 49, 591–602.
- DELAFORGE, M., JAOUEN, M. and MANSUY, D., 1983, Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Biochemical Pharmacology, 32, 2309–2318.
- DELAFORGE, M., SARTORI, E. and MANSUY, D., 1988, /n vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin. Chemko-Biological Interactions, 68, 179–188.
- ESTABROOK, R. W., HILDEBRANDT, A. G., BARON, J., NETTER, K. J. and LEIBMAN, K., 1971, A new spectral intermediate associated with cytochrome P-450 function in liver microsomes. Biochemical and Biophysical Research Communications, 42, 132–139.
- ESUMI, Y., ZIN, Y., BAN, S., NINOMIYA, S., HAYASHI, K., YOKOSHIMA, T., YAMAMOTO, T., HIRAYAMA M., SAITOH, K. and OKui, K., 1988, Absorption, distribution, metabolism and excretion of RU 28965 in animals. Chemotherapy, 36, 148–163.
- FRANKLIN, M. R.,1991, Cytochrome P450 metabolite intermediate complexes from macrolide antibiotics and related compounds. Methods in Enzymology, 206, 559–573.
- GUENGERICH, F. P., 1994, Analysis and characterization of enzymes. In Principles and Methods of Toxicology, edited by A. W. Hayes (New York: Raven), pp. 1259–1313.
- KOYAMA, M., TATENO, M., SHIROTSUKA, M., YAMAMOTO, M., HIRAYAMA, M., SAITOH, K. and OKUI, K., 1988, Absorption, metabolism and excretion of RU 28965 in humans. Chemotherapy, 36, 164-183. LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
- NASH, T., 1953, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal, 55, 416–421.
- OHMORI, S., ISHII, I., KURIYA, S., TANIGUCHI, T., RIKIHISA, T., HIROSE, S., KANAKUBO, Y. and KITADA M., 1993, Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats. Drug Metabolism and Disposition, 21, 358–363.
- OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
- PERITI, P., MAZZEI, T., MINI, E. and NOVELLI, A., 1992, Pharmacokinetic drug interactions of macrolides. Clinical Pharmacokinetics, 23, 106–131.
- SPATZENEGGER, M. and JAEGER, W., 1995, Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Reviews, 27, 397–417.
- TINEL, M., DESCATOIRE, V., LARREY, D., LOEPER, J., LABBE, G., LETTERON, P. and PESSAYRE, D., 1989, Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. Journal of Pharmacology and Experimental Therapeutics, 250, 746–751.
- YAMAZAKI, H., HIROKI, S., URANO, T., INouE, K. and SHIMADA, T., 1996a, Effects of roxithromycin, erythromycin and troleandomycin on their N-demethylation by rat and human cytochrome P450 enzymes. Xenobiotica, 26, 1143–1153.
- YAMAZAKI, H., NAKANO, M., IMAI, Y., UENG, Y.-F., GUENGERICH, F. P. and SHIMADA, T., 1996b, Roles of cytochrome b, in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Archives of Biochemistry and Biophysics, 325, 174–182.
- YAMAZAKI, H., URANO, T., HIROKI, S. and SHIMADA, T., 1996c, Effects of erythromycin and roxithromycin on oxidation of testosterone and nifedipine catalyzed by CYP3A4 in human liver microsomes. Journal of Toxicological Sciences, 21, 215–226.